Navigation Links
UC research shows employer-based weight loss programs are helpful
Date:7/1/2008

CINCINNATIA new review of studies from the University of Cincinnati (UC) shows that a little shove from the workplace may actually be the ticket to dropping weight.

According to Michael Benedict, MD, and colleagues at UC, employer-based programs for weight loss are modestly effective at helping workers take off extra pounds.

"Worksite-based programs do tend to result in weight loss for the people that participate in them," says Benedict, co-author of the study and researcher in the department of internal medicine.

The review appears in the July-August issue of the American Journal of Health Promotion.

Benedict and colleagues looked at 11 studies published since 1994 to determine their results.

Most of the programs involved education and counseling designed to improve diet and increase physical activity and lasted anywhere from two to 18 months. Forty-six percent of the studies involved low-intensity interventions, 18 percent were moderate intensity and 36 percent were high intensity.

Benedict says that intensity may be an important factor when it comes to weight loss. He added that programs incorporating face-to-face contact with subjects more than once a month appeared to be more effective than other programs.

In comparison, participants in higher intensity programs lost an average of 2.2 pounds to almost 14 pounds, while non-participants ranged from a loss of 1.5 pounds to a gain of 1.1 pounds.

"Most employed adults in the U.S. spend nearly half of their waking hours at their place of employment," Benedict says. "Worksite based programs have great potential to positively impact our current obesity epidemic.

However, Benedict says it was difficult to draw conclusions about weight-loss maintenance.

"Participants in these programs may lose weight, but it is unclear what happens after the fact, as weight maintenance has not been studied," he says.

There
'/>"/>

Contact: Katie Pence
katie.pence@uc.edu
513-558-4561
University of Cincinnati
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Researcher receives $4 million from RWJ Foundation to study health quality reform project
2. Ikaria(R) Strengthens Research & Development Team
3. Millar Instruments Offers Telemetry Systems Through Worldwide Distribution Agreement with Telemetry Research Ltd
4. Data Published in Anticancer Research Show ChemoFx(R) Assay Results Correlate With Outcomes in Breast Cancer
5. Education More Important Than Immigration to Solve Nursing Shortage, Research Shows
6. Cancer cells revert to normal at specific signal threshold, Stanford researchers find
7. Spiritual effects of hallucinogens persist, Johns Hopkins researchers report
8. Research Links Low HDL Levels With Memory Loss
9. More severe bone infections, health complications in children linked to MRSA, researchers find
10. Contract Research Development Debuts at MD&M Touting Expertise, Innovation and Collaboration
11. Photos: For the First Time Researchers Show Reversal of an Aging Marker in the Human Retina Correlated with Visual Improvement Using a Nutraceutical Matrix (Longevinex(R))
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...eClaim Revenue Gateway Alleviates Insurance Claim ...roviders , , ATLANTA, Dec. 2 /PRNewswire-Fi...day announced a new healthcare receivables solutio...s well as hospitals. SunTrust eClaim Revenue Gatew...issions as well as payment collection and processi...
(Date:12/2/2008)...o., Dec. 2 MicroPhage, Inc., htt... M. Taussig, MD has joined,the company,s Board of...onal,Jewish Medical and Research Center in Denver...espiratory diseases, from 1993 to 2006. His medic...I have followed MicroPhage extensively and am impr...
(Date:12/2/2008)...s Missing Opportunities to Connect - , , - ...escription Drug Abuse Dangers - , , NEW YOR...Partnership for a Drug-Free America and MetLife Fo...ail or text messaging to communicate with their t...nect with their kids about drug and alcohol use. T...
(Date:12/2/2008)...OCKVILLE, Md., Dec. 2 F...iods and increased supervision of work hour limits...nment, according to a new Institute of Medicine re... and Quality. , , The report is the result...ewed the relationship between residents, work sche...
Breaking Medicine News(10 mins):Health News:Healthcare Providers Now Able to Perform Real-Time Patient Eligibility Verification 2Health News:Healthcare Providers Now Able to Perform Real-Time Patient Eligibility Verification 3Health News:Healthcare Providers Now Able to Perform Real-Time Patient Eligibility Verification 4Health News:MicroPhage Selects Lynn Taussig, MD for Board of Directors 2Health News:Bridging the Technology Gap: Study Confirms Teens Open to Discussing Drugs and Alcohol With Parents By Email, Cell Phones 2Health News:Bridging the Technology Gap: Study Confirms Teens Open to Discussing Drugs and Alcohol With Parents By Email, Cell Phones 3Health News:New Report Recommends Strategies to Reduce Medical Resident Fatigue-Related Errors and Improve Training 2Health News:New Report Recommends Strategies to Reduce Medical Resident Fatigue-Related Errors and Improve Training 3Health News:New Report Recommends Strategies to Reduce Medical Resident Fatigue-Related Errors and Improve Training 4
...n with prostate cancer who receive a common medica...uce // the risk of recurrence after surgery may be...he research showed men treated with androgen depri...er run a higher risk of developing the bone-thinni...
... might benefit from the implantation of cardiac pa...t the conclusion // after studying 20 patients wit...currence of interrupted heart rhythm during seizur...ring seizures might be responsible for the higher ...
...e drug rolipram in mice shows promise for possible...say researchers according to a new study. Alzheime... the elderly with typical symptoms being memory lo... changes. The main factor in the cause of AD is th...
...vaginal birth after first delivering a child via c...r newborns at risk,// say researchers based on fin... anything will go wrong is extremely small, uterin...n due to lack of oxygen (hypoxic-ischemic encephal...
Other Medicine News:
(Date:12/1/2008)...ARD, Denmark, December 1 ...with the intent to procure an MVA-based,third ge...ment Services,Canada, on behalf of the Canadian D...ract to Bavarian Nordic for the delivery of IMVAMU... use IMVAMUNE(R) as part of the,country,s bio-pre...
(Date:11/30/2008)...ec. 1 Abnormalities in ...in children with autism spectrum disorder by using...y presented today at the annual meeting of the Rad..., "Using MEG, we can record the tiny magnetic fi...aid Timothy Roberts, Ph.D., vice chair of research...
(Date:11/26/2008)...information density, automation and intelligent cl...trasound to an all new level , , CHICAGO, I...Healthcare ( www.siemens.com/healthcare ) highli...Scanner (ABVS)(1), the world,s first multi-use, a...4th Scientific Assembly and Annual Meeting of the ...
(Date:11/25/2008)...FRANCISCO, Calif., Nov. 25 Proteol...nt of novel therapeutics that target,protein degr..., today,announced that data from two ongoing Phas...eloma will be presented at the upcoming 50th Annua...ASH). Carfilzomib is the first in a new class,of...
Breaking Medicine Technology:The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 2The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 3Brain Waves Show Sound Processing Abnormalities in Autistic Children 2Brain Waves Show Sound Processing Abnormalities in Autistic Children 3Siemens Introduces New Standard of Care for Breast Ultrasound 2Siemens Introduces New Standard of Care for Breast Ultrasound 3Siemens Introduces New Standard of Care for Breast Ultrasound 4Siemens Introduces New Standard of Care for Breast Ultrasound 5Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 2Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 3Ohio Company to Debut Turnkey Marketing Material During Florida National Dental Convention 20824 1Ohio Company to Debut Turnkey Marketing Material During Florida National Dental Convention 20824 2Research Explains How Advanced Prostate Cancer Becomes Resistant to Androgen Deprivation Therapy 2287 1Research Explains How Advanced Prostate Cancer Becomes Resistant to Androgen Deprivation Therapy 2287 2Research Explains How Advanced Prostate Cancer Becomes Resistant to Androgen Deprivation Therapy 2287 3Research Explains How Advanced Prostate Cancer Becomes Resistant to Androgen Deprivation Therapy 2287 4Bamboo instant houses will soon shelter Sichuan quake victims 3504 1Bamboo instant houses will soon shelter Sichuan quake victims 3504 2Is tap water safe for expectant mothers 3F 20821 1Is tap water safe for expectant mothers 3F 20821 2
...therapeutic approach for the treatment,of early an... 2007 /PRNewswire-FirstCall/ - AEterna,Zentaris In...,focused on endocrine therapy and oncology, today ...ts growth hormone-releasing,hormone (GHRH) antagon...ciation for Cancer Research (AACR) Annual Meeting ...
...pr 16, 2007 - Arsenic, a naturally,occurring eleme...r,2,000 years, and even now remains a venerable co..., Today, due in measure to the efforts of investig...ancer Research Foundation,s,(SWCRF) "Institute Wit...ed in therapy for the treatment of certain types o...
Other Medicine Technology:AEterna Zentaris Discloses In Vivo Data for its GHRH Antagonist,JMR-132 at the AACR Annual Meeting in Los Angeles 2AEterna Zentaris Discloses In Vivo Data for its GHRH Antagonist,JMR-132 at the AACR Annual Meeting in Los Angeles 3Research Supported by Samuel Waxman Cancer Research Foundation,Discovers Mode of Action of Arsenic-Based Drugs in Destroying,Cancer Cells 2Research Supported by Samuel Waxman Cancer Research Foundation,Discovers Mode of Action of Arsenic-Based Drugs in Destroying,Cancer Cells 3
For determination of HDL-cholesterol in serum and plasma. For Hitachi 717. Specific immunochemical inhibition of non-HDL-lipoproteins. Excellent correlation with established reference methods. Endpoi
Cholesterol/HDL Standard 50 mg/dl.
Intended for the in vitro precipitation of very low density and low density lipoproteins in serum or plasma. Single vial, dry powder precipitating reagent. Total cholesterol reagent not included.
Ready to use liquid single reagent for automated chemistry analyzers. Linearity to 1000 mmol/L
Medicine Products: